Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Submitted by
admin
on March 8, 2014 - 10:49am
Source:
Pharmabiz
News Tags:
SVR12
Boehringer Ingelheim
HCV
HIV
hepatitis
hepatitis C
Headline:
Boehringer Ingelheim reports positive phase 3 SVR12 results in HCV/HIV co-infected patients treated with faldaprevir
Do Not Allow Advertisers to Use My Personal information
